Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

The FDA has granted a fast review for Horizon Therapeutics’ teprotumumab for active thyroid eye disease (TED), a rare vision-threatening autoimmune condition. After accepting Horizon’s filing ...

When it comes to fighting rare diseases ... rare and ultra-rare diseases.” In an effort to give researchers the best possible start when developing treatments for eye diseases, The Foundation ...

On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 ...